TOPICAL ADMINISTRATION OF PROSTAGLANDIN-E1 WITH IONTOPHORESIS FOR SKIN FLAP VIABILITY

Citation
S. Asai et al., TOPICAL ADMINISTRATION OF PROSTAGLANDIN-E1 WITH IONTOPHORESIS FOR SKIN FLAP VIABILITY, Annals of plastic surgery, 38(5), 1997, pp. 514-517
Citations number
18
Categorie Soggetti
Surgery
Journal title
ISSN journal
01487043
Volume
38
Issue
5
Year of publication
1997
Pages
514 - 517
Database
ISI
SICI code
0148-7043(1997)38:5<514:TAOPWI>2.0.ZU;2-W
Abstract
This study was performed to investigate the capability of iontophoreti c delivery of prostaglandin E1 (PGE1) and the effect of this treatment on the viability of skin flaps on the rat dorsum model as described b y Hammond and Ronald in 1993, The PGE1 level in the tissue sample unde r the electrode was assessed with radioimmunoassay. The iontophoretic treatment (for 20 minutes at 4 mA) with PGE1 solution (20 mu g PGE1 in 2 mi saline) showed a significant increase of PGE1 in the flap tissue under the negative electrode (p < 0.05). Very little increase was obs erved after the iontophoresis of saline alone. This was not statistica lly significant, lontophoretic treatment was given for 5 consecutive d ays following flap elevation. The survival area on the seventh postope rative day was significantly greater in the PGE1-treated flaps than th at of either the control or saline-treated flaps. These results confir m the beneficial effect of iontophoretic treatment with PGE1 on the au gmentation of skin flap viability.